The company intends to use the funds to advance two clinical-stage pipeline assets targeting rare muscular and central nervous system disorders and to expand the AMO Pharma pipeline through acquisition of additional development-stage products.
Org chart
Collapse
Teams
This company has no teams yet
Offices
FUJIFILM Diosynth Biotechnologies
33 followers
Lead Exposure Elimination Project
1 follower
Avalere Health
5 followers
GSK
573 followers
AstraZeneca
565 followers
Astellas Pharma
63 followers
Otsuka Group
22 followers
Hikma Pharmaceuticals
19 followers
Oxford Nanopore Technologies
19 followers
Indivior
7 followers
Boots UK
26 followers
PTC Therapeutics
13 followers